| Financial Year |
March 31 2023 |
| Monetary Funds |
2,903,558,356.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,681,806.30 |
| Accounts Receivable |
1,035,913,617.30 |
| Advances to Suppliers |
87,103,867.22 |
| Other Receivables |
42,815,835.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
81,489,655.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
365,796,412.64 |
| Total Current Assets |
4,567,927,572.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
334,065,461.34 |
| Investment Properties |
-- |
| Fixed Assetes |
1,452,407,990.62 |
| Under-construction Projects |
71,200,123.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,389,613,247.29 |
| R&D expenses |
266,045,156.53 |
| Goodwill |
1,069,386,099.12 |
| Long-Term Deferred and Prepaid Expenses |
20,364,856.52 |
| Deferred Income Tax Assets |
81,797,852.96 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,085,799,000.91 |
| Total Assets |
10,653,726,573.32 |
| Short-Term Loans |
3,751,488.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,773,057.07 |
| Accounts Payable |
371,948,179.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
271,541,249.25 |
| Taxes Payable |
65,862,143.09 |
| Interest Payable |
-- |
| Dividend Payable |
1,977,573.00 |
| Other payables |
385,123,059.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,781,430.04 |
| Other Current Liabilities |
22,774,039.49 |
| Sub-Total of Current Liabilities |
3,453,456,558.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,489,791.55 |
| Other Non-Current Liabilities |
31,401,312.50 |
| Sub-Total of Non-Current Liabilities |
238,207,031.22 |
| Total Liabilities |
3,691,663,589.56 |
| Paid-In Capital(Or Share Stock) |
1,191,386,962.00 |
| Capital Surplus |
2,954,276,353.49 |
| Surplus Reserve |
578,215,753.46 |
| LESS:Treasury Stock |
730,024,675.32 |
| Undistributed Profits |
2,605,026,847.00 |
| Minority Stockholder's Interest |
519,938,129.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,442,124,854.11 |
| Owner's Equity（Stockholder's Equity） |
6,962,062,983.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,653,726,573.32 |
